Biphasic vasodilator action of troglitazone on the renal microcirculation

被引:0
作者
Arima, S [1 ]
Kohagura, K [1 ]
Takeuchi, K [1 ]
Taniyama, Y [1 ]
Sugawara, A [1 ]
Ikeda, Y [1 ]
Abe, M [1 ]
Omata, K [1 ]
Ito, S [1 ]
机构
[1] Tohoku Univ, Sch Med, Ddiv Nephrol Endocrinol & Vasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷 / 02期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recent studies have demonstrated that thiazolidinediones, novel antidiabetic compounds that improve the insulin sensitivity, lower BP and decrease urinary protein excretion. However, neither the target vasculature nor the underlying mechanism for their actions is well understood. In this study, the action of troglitazone (Tro), a thiazolidinedione compound, on the glomerular afferent (Af-Arts) and efferent (Ef-Arts) arterioles, crucial vascular segments to the control of glomerular hemodynamics, were directly examined. Rabbit Af-Arts or Ef-Arts were microdissected from the superficial cortex and perfused at constant pressure. Increasing doses of Tro (10(-8) to 10(-5) M) were added to both the bath and lumen of preconstricted arterioles. In Af-Arts, Tro caused dose-dependent and biphasic dilation. Tro at 10(-5) M increased the diameter by 28 +/- 6% (n = 8, P < 0.01) until 20 min, with the diameter remaining at this level for 60 min, and then Tro began to dilate Af-Arts again. At 120 min, Tro at 10(-5) M further increased the diameter by 23 +/- 4% (n = 6). Disrupting the endothelium had no effect on either dilation (n = 7 or n = 5). Pretreatment with SKF 96365 (50 μM), which inhibits both voltage- and receptor-operated calcium channels, abolished the early-phase dilation without affecting the late-phase dilation; 20 or 120 min after adding Tro at 10(-5) M, the diameter increased by 4 +/- 2% (n = 7) or 28 +/- 3% (n = 6), respectively. In contrast to Af-Arts, Tro caused monophasic dilation in Ef-Arts; Tro at 10(-5) M did not cause significant dilation until 80 min, and at 120 min the diameter increased by 37 +/- 4% (n = 5). These results suggest that in the Af-Art Tro has biphasic endothelium-independent vasodilator action, which is partly mediated by an inhibition of calcium influx. This vasodilator action may play a role in the BP-lowering effect of Tro. In addition, by dilating the postglomerular Ef-Art, Tro may decrease the glomerular capillary pressure and hence the excretion of urinary protein.
引用
收藏
页码:342 / 349
页数:8
相关论文
共 47 条
  • [1] Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
    Andersen, S
    Tarnow, L
    Rossing, P
    Hansen, BV
    Parving, HH
    [J]. KIDNEY INTERNATIONAL, 2000, 57 (02) : 601 - 606
  • [2] HIGH GLUCOSE AUGMENTS ANGIOTENSIN-II ACTION BY INHIBITING NO SYNTHESIS IN IN-VITRO MICROPERFUSED RABBIT AFFERENT ARTERIOLES
    ARIMA, S
    ITO, S
    OMATA, K
    TAKEUCHI, K
    ABE, K
    [J]. KIDNEY INTERNATIONAL, 1995, 48 (03) : 683 - 689
  • [3] Arima S, 2000, J HYPERTENS, V18, pS31
  • [4] ARIMA S, 1996, KIDNEY INT S55, V49, pS132
  • [5] BLOOD-PRESSURE-LOWERING BY PIOGLITAZONE - EVIDENCE FOR A DIRECT VASCULAR EFFECT
    BUCHANAN, TA
    MEEHAN, WP
    JENG, YY
    YANG, D
    CHAN, TM
    NADLER, JL
    SCOTT, S
    RUDE, RK
    HSUEH, WA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 354 - 360
  • [6] SEGMENTALLY DISTINCT EFFECTS OF DEPOLARIZATION ON INTRACELLULAR [CA2+] IN RENAL ARTERIOLES
    CARMINES, PK
    FOWLER, BC
    BELL, PD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (05): : F677 - F685
  • [7] Cooper ME, 1996, J HYPERTENS, V14, pS11
  • [8] DEVERAJ S, 1996, J CLIN INVEST, V98, P756
  • [9] INSULIN RESISTANCE IN ESSENTIAL-HYPERTENSION
    FERRANNINI, E
    BUZZIGOLI, G
    BONADONNA, R
    GIORICO, MA
    OLEGGINI, M
    GRAZIADEI, L
    PEDRINELLI, R
    BRANDI, L
    BEVILACQUA, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (06) : 350 - 357
  • [10] 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA
    FORMAN, BM
    TONTONOZ, P
    CHEN, J
    BRUN, RP
    SPIEGELMAN, BM
    EVANS, RM
    [J]. CELL, 1995, 83 (05) : 803 - 812